Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Délégation Paris 5 · Université Paris Cité · +7 more institutions
Abstract
We introduce the Microenvironment Cell Populations-counter (MCP-counter) method, which allows the robust quantification of the absolute abundance of eight immune and two stromal cell populations in heterogeneous tissues from transcriptomic data. We present in vitro mRNA mixture and ex vivo immunohistochemical data that quantitatively support the validity of our method's estimates. Additionally, we demonstrate that MCP-counter overcomes several limitations or weaknesses of previously proposed computational approaches. MCP-counter is applied to draw a global picture of immune infiltrates across human healthy tissues and non-hematopoietic human tumors and recapitulates microenvironment-based patient…
Citation impact
- FWCI
- 30.81
- Percentile
- 100%
- References
- 27
Authors
11- ÉBÉtienne BechtCorresponding
Délégation Paris 5, Université Paris Cité, Sorbonne Université, Inserm, Centre de Recherche des Cordeliers, La Ligue Contre le Cancer
- NANicolás A. Giraldo
Sorbonne Université, Inserm, Délégation Paris 5, Université Paris Cité, Centre de Recherche des Cordeliers
- LLLaetitia Lacroix
Délégation Paris 5, Inserm, Centre de Recherche des Cordeliers, Université Paris Cité, Sorbonne Université
- BBBénédicte Buttard
Université Paris Cité, Délégation Paris 5, Centre de Recherche des Cordeliers, Sorbonne Université, Inserm
- NENabila Elarouci
La Ligue Contre le Cancer
Topics & keywords
- Biology
- Stromal cell
- Immune system
- Tumor microenvironment
- Population
- Transcriptome
- Adenocarcinoma
- Gene expression
- Good health and well-being
Funding
- DADepartamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS)
- INInstitut National de la Santé et de la Recherche Médicale
- FAFondation ARC pour la Recherche sur le Cancer
- UPUniversité Paris Descartes
- UPUniversité Pierre et Marie Curie
- INInstitut National Du CancerAward: PLBIO09-088
- CICancéropôle Ile de France
- LILabex Immuno-Oncology